HR 6294 · 115th Congress · Health

REVAMP Act

Introduced 2018-06-28· Sponsored by Rep. Shimkus, John [R-IL-15]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2018-06-28)

Plain Language Summary

[AI summary unavailable — showing source text] Re-Valuing Anti-Microbial Products Act of 2018 or the REVAMP Act This bill amends the Federal Food, Drug, and Cosmetic Act to provide for an award of 12 additional months of market exclusivity to a drug manufacturer for a drug designated as a "priority antimicrobial product." (A priority antimicrobial product is intended to treat or prevent a disease attributable to a multi-drug resistant bacterial or fungal pathogen for which there is a critical unmet medical need.)…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (2)

2 Democrats
Rep. Cárdenas, Tony [D-CA-29]CA
Rep. Eshoo, Anna G. [D-CA-18]CA